Immunohistochemical Expression of RAGE and Its Ligand (S100A9) in Cervical Lesions

Cell Biochemistry and Biophysics

Volumn 66, Issue 3, 2013, Pages 843-850

  Zhu, Xuejie ^a   Jin, Lanying ^b   Zou, Shuangwei ^b   Shen, Qi ^b   Jiang, Wenxiao ^b   Lin, Wenjing ^b   Zhu, Xueqiong ^b  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cervical intraepithelial neoplasia; RAGE; S100A9; Squamous cervical cancer

Indexed keywords

EID: 84880932119     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-013-9515-x     Document Type: Article

References (27)

1. Petignat, P., & Roy, M. (2007). Diagnosis and management of cervical cancer. BMJ, 335, 765-768.
2. Tiltman, A. J. (2005). The pathology of cervical tumours. Best Practice & Research Clinical Obstetrics & Gynaecology, 19, 485-500.
3. Logsdon, C. D., Fuentes, M. K., Huang, E. H., et al. (2007). RAGE and RAGE ligands in cancer. Current Molecular Medicine, 7, 777-789.
4. Bucciarelli, L. G., Wendt, T., Rong, L., et al. (2002). RAGE is a multiligand receptor of the immunoglobulin superfamily: Implications for homeostasis and chronic disease. Cellular and Molecular Life Sciences, 59, 1117-1128.
5. Douqan, M., & Dranoff, G. (2008). Inciting inflammation: The RAGE about tumor promotion. Journal of Experimental Medicine, 205, 267-270.
6. Hiwatashi, K., Ueno, S., Abeyama, K., et al. (2008). A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC. Annals of Surgical Oncology, 15, 923-933.
7. 2+ binding proteins of neutrophils and monocytes. Journal of Leukocyte Biology, 53, 197-204.
8. Gebhardt, C., Németh, J., Angel, P., et al. (2006). S100A8 and S100A9 in inflammation and cancer. Biochemical Pharmacology, 72, 1622-1631.
9. Chao, A., Wang, T. H., Lee, Y. S., et al. (2006). Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression. International Journal of Cancer, 119, 91-98.
10. Zhu, X., Lv, J., Yu, L., et al. (2009). Proteomic identification of differentially-expressed proteins in squamous cervical cancer. Gynecologic Oncology, 112, 248-256.
11. Turovskaya, O., Foell, D., Sinha, P., et al. (2008). RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis, 29, 2035-2043.
12. Hermani, A., Hess, J., De Servi, B., et al. (2005). Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clinical Cancer Research, 11, 5146-5152.
13. Sasahira, T., Kirita, T., Bhawal, U. K., et al. (2007). Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinoma. Histopathology, 51, 166-172.
14. Arai, K., Teratani, T., Kuruto-Niwa, R., et al. (2004). S100A9 expression in invasive ductal carcinoma of the breast: S100A9 expression in adenocarcinoma is closely associated with poor tumour differentiation. European Journal of Cancer, 40, 1179-1187.
15. Moss, S. F., & Blaser, M. J. (2005). Mechanisms of disease: Inflammation and the origins of cancer. Nature Clinical Practice Oncology, 2, 90-97.
16. Huang, E. H., Park, J. C., Appelman, H., et al. (2006). Induction of inflammatory bowel disease accelerates adenoma formation in min ± mice. Surgery, 139, 782-788.
17. Bhawal, U. K., Ozaki, Y., Nishimura, M., et al. (2005). Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma. Oncology, 69, 246-255.
18. Sasahira, T., Kirita, T., Bhawal, U. K., et al. (2007). The expression of receptor for advanced glycation end products is associated with angiogenesis in human oral squamous cell carcinoma. Virchows Archiv, 450, 287-295.
19. Landesberg, R., Woo, V., Huang, L., et al. (2008). The expression of the receptor for glycation endproducts (RAGE) in oral squamous cell carcinomas. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics, 105, 617-624.
20. Kong, J. P., Ding, F., Zhou, C. N., et al. (2004). Loss of myeloid-related proteins 8 and myeloid-related proteins 14 expression in human esophageal squamous cell carcinoma correlates with poor differentiation. World Journal of Gastroenterology, 10, 1093-1097.
21. Sewell, D. A., Yuan, C. X., & Robertson, E. (2007). Proteomic signatures in laryngeal squamous cell carcinoma. Journal of Oto-Rhino-Laryngology and Its Related Specialties, 69, 77-84.
22. He, Q. Y., Chen, J., Kung, H. F., et al. (2004). Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics, 4, 271-278.
23. Arai, K., Teratani, T., Nozawa, R., et al. (2001). Immunohistochemical investigation of S100A9 expression in pulmonary adenocarcinoma: S100A9 expression is associated with tumor differentiation. Oncology Reports, 8, 591-596.
24. Ghavami, S., Rashedi, I., Dattilo, B. M., et al. (2008). S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. Journal of Leukocyte Biology, 83, 1484-1492.
25. Gebhardt, C., Riehl, A., Durchdewald, M., et al. (2008). RAGE signaling sustains inflammation and promotes tumor development. Journal of Experimental Medicine, 205, 275-285.
26. Garg, A. K., Jhingran, A., Klopp, A. H., et al. (2010). Expression of nuclear transcription factor kappa B in locally advanced human cervical cancer treated with definitive chemoradiation. International Journal of Radiation Oncology Biology Physics, 78, 1331-1336.
27. Sheikh, A. A., Vimalachandran, D., Thompson, C. C., et al. (2007). The expression of S100A8 in pancreatic cancer-associated monocytes is associated with the Smad4 status of pancreatic cancer cells. Proteomics, 7, 1929-1940.